Brief: Enanta Pharmaceuticals Q2 Revenue USD 14.926 Million
12/05/2025 21:01
May 12 (Reuters) - Enanta Pharmaceuticals Q2 net income USD -22.644 million. Q2 pretax profit USD -23.949 million Q2 operating expenses USD 39.453 million Q2 operating income USD -24.527 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates